Agilent Teams with Indian Institute of Technology Delhi to Enhance Biotherapeutics
January 29 2020 - 10:00PM
Business Wire
Agilent and IIT Delhi to set up incubator site for bioanalytical
science
Agilent Technologies Inc. (NYSE: A) today announced that it is
joining forces with the Indian Institute of Technology Delhi (IIT
Delhi) to promote biopharmaceutical research.
Agilent and IIT Delhi signed a memorandum of understanding under
which, Agilent, a leader in the biopharma space, is contributing
funds to support the incubator at IIT New Delhi to support
researchers at the institute establish global best practices for
identifying and characterizing biopharmaceuticals. The research
conducted by IIT Delhi examines and reports on the quality of
biotherapeutic products for the Indian market.
Visiting the IIT Delhi campus today, Agilent CEO, Mike McMullen,
spoke about Agilent’s history of innovation, focus on research and
academia, and vision for the future. Likewise, the institute’s
Director, Prof. V. Ramgopal Rao, spoke about the institute’s
mission and role in promoting collaborations between academia and
industry.
Agilent will be contributing funds to the IIT Delhi incubator
site, as a part of its corporate social responsibility initiative,
with the goal of enhancing the quality and safety of
biotherapeutics. The aim is to offer world-class training to
researchers from academia and industry on protein
characterization.
The setup will be under the DBT Center of Excellence for
Biopharmaceutical Technology (CBT) and will support incubated
startups at IIT Delhi performing protein analysis, which results
will provide critical information to policy makers for ensuring
safe and efficacious biotherapeutic products in India.
“We are happy to be associated with Agilent,” said Prof. Anurag
S. Rathore (IIT Delhi), Coordinator of the CBT. “Agilent’s broad
range of technologies will further boost our efforts at the Centre
of Excellence for Biopharmaceutical Technology. This mutually
constructive and productive partnership will hopefully lead to
promising results for the entire biotherapeutics ecosystem.”
“We are excited to embark on this initiative with IIT Delhi, an
institute with the country’s brightest minds engaged in research
and technology,” said Bharat Bhardwaj, country general manager,
Agilent India. “Agilent’s relationship with IIT Delhi goes back
decades. The new memorandum of understanding that we have signed
will further strengthen our relationship and will enhance the
ability to do cutting-edge research, which can be used to improve
the quality of life for the community at large, through the
application of new innovations.”
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is a global leader in life
sciences, diagnostics and applied chemical markets. Now in its 20th
year as an independent company delivering insight and innovation
toward improving the quality of life, Agilent instruments,
software, services, solutions and people provide trusted answers to
customers' most challenging questions. The company generated
revenue of $5.16 billion in fiscal 2019 and employs 16,300 people
worldwide. Information about Agilent is available at
www.agilent.com. To receive the latest Agilent news, subscribe to
the Agilent Newsroom. Follow Agilent on LinkedIn, Twitter, and
Facebook.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200129005864/en/
Victoria Wadsworth-Hansen Agilent Technologies +1 408 553 2005
+45 2933 6980 victoria.wadsworth-hansen@agilent.com
Agilent Technologies (NYSE:A)
Historical Stock Chart
From Mar 2024 to Apr 2024
Agilent Technologies (NYSE:A)
Historical Stock Chart
From Apr 2023 to Apr 2024